MedDataX Logo

Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

NCT ID: NCT03895723

Last Updated: 2019-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-01

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To examine survival of patients who underwent minimally invasive versus open liver resection for colorectal cancer with liver metastases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

the minimally invasive procedure contain laparoscopic or robotic surgery

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Liver Metastasis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Colorectal liver metastasis Minimally invasive surgery Robotic surgery Laparoscopic surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Arm A: minimally invasive surgery Arm B: open
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The assessor was masking for patients treatment arms

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Minimally Invasive surgery

the intevention of Minimally Invasive procedure contains laparoscopic and robotic liver resection

Group Type EXPERIMENTAL

laparoscopic and robotic liver resection

Intervention Type PROCEDURE

laparoscopic and robotic procedure for liver resection

Open surgery

the open surgery means traditional open surgery for liver resection

Group Type OTHER

open surgery

Intervention Type PROCEDURE

using open surgery procedure for liver resection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

laparoscopic and robotic liver resection

laparoscopic and robotic procedure for liver resection

Intervention Type PROCEDURE

open surgery

using open surgery procedure for liver resection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients were diagnosed with colorectal cancer liver metastases
* without extra-hepatic liver metastases
* age were within 18-75 yeas
* the numbers of metastases more than 3
* the maximal tumor size of liver metastases more than 10 cm

Exclusion Criteria

* liver metastases were unresectable.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xu jianmin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xu jianmin

Director of colorectal cancer center

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wenju Chang

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wenju Chang, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RSRCLM-02

Identifier Type: -

Identifier Source: org_study_id